Aspen Aerogels’ (ASPN) “Sell (D)” Rating Reiterated at Weiss Ratings

Weiss Ratings reiterated their sell (d) rating on shares of Aspen Aerogels (NYSE:ASPNFree Report) in a research note published on Wednesday,Weiss Ratings reports.

Other analysts also recently issued reports about the stock. Canaccord Genuity Group cut their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Barclays downgraded shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and raised their price target for the company from $7.00 to $16.00 in a report on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $19.50.

Check Out Our Latest Stock Report on ASPN

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $7.96 on Wednesday. Aspen Aerogels has a one year low of $4.16 and a one year high of $26.90. The company’s 50-day moving average is $7.15 and its 200 day moving average is $6.48. The company has a market capitalization of $655.17 million, a price-to-earnings ratio of -2.09 and a beta of 2.80. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. During the same period in the prior year, the firm posted $0.21 EPS. Aspen Aerogels’s revenue for the quarter was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. Sell-side analysts expect that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. This represents a 18.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.30% of the stock is owned by company insiders.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC lifted its stake in shares of Aspen Aerogels by 1,094.8% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock worth $28,000 after purchasing an additional 4,390 shares during the period. SBI Securities Co. Ltd. lifted its stake in shares of Aspen Aerogels by 67.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after purchasing an additional 2,551 shares during the period. Tower Research Capital LLC TRC raised its stake in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after acquiring an additional 4,693 shares during the period. Acadian Asset Management LLC bought a new stake in Aspen Aerogels during the 1st quarter worth approximately $43,000. Finally, Banque Cantonale Vaudoise bought a new stake in Aspen Aerogels during the 1st quarter worth approximately $45,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Stories

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.